Related references
Note: Only part of the references are listed.MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells
Kristine Misund et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
H. Tilly et al.
ANNALS OF ONCOLOGY (2012)
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Tina Marie Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Nathalie A. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC
T. Holien et al.
LEUKEMIA (2012)
Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase 1b study
Robert Scott Miller et al.
MALARIA JOURNAL (2012)
Latest advances and current challenges in the treatment of multiple myeloma
Anuj Mahindra et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Youyou Tu
NATURE MEDICINE (2011)
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
Jin-Jian Lu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells
Hao Chen et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Rene Handrick et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFκB p65
Shihui Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Artemisinins: mechanisms of action and potential for resistance
S Krishna et al.
DRUG RESISTANCE UPDATES (2004)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria
TME Davis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
